Seeing Is Believing
Currently out of the existing stock ratings of Sean Lavin, 92 are a BUY (77.31%), 27 are a HOLD (22.69%).
Analyst Sean Lavin works with a stock forecast success ratio of 84.26% fulfilled within 260.05 days on average. Previously, Sean Lavin worked at BTIG.
Sean Lavin’s has documented 207 price targets and ratings displayed on 21 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MASI, Masimo at 09-Aug-2023.
Analyst best performing recommendations are on TRXC (ASENSUS SURGICAL).
The best stock recommendation documented was for TRXC (ASENSUS SURGICAL) at 5/9/2018. The price target of $52 was fulfilled within 40 days with a profit of $24.96 (92.31%) receiving and performance score of 23.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
388
$6.98 (1.83%)
355
1 years 5 months 22 days ago
2/5 (40%)
$14.49 (3.88%)
88
Hold
380
$-1.02 (-0.27%)
235
1 years 5 months 22 days ago
1/2 (50%)
$6.49 (1.74%)
36
Hold
380
$-1.02 (-0.27%)
350
1 years 5 months 23 days ago
24/41 (58.54%)
$2.18 (0.58%)
138
Buy
300
$-81.02 (-21.26%)
425
1 years 6 months 12 days ago
1/2 (50%)
$57.23 (23.57%)
20
Sell
235
$-146.02 (-38.32%)
275
1 years 9 months 9 days ago
6/8 (75%)
$-33.23 (-12.39%)
142
What Year was the first public recommendation made by Sean Lavin?